# Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction

> **NCT07230886** · NA · NOT_YET_RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 50 (estimated)

## Conditions studied

- Primary Graft Dysfunction

## Interventions

- **DEVICE:** Xo Port Organ Preservation System
- **DEVICE:** Standard of Care - Ice packs

## Key facts

- **NCT ID:** NCT07230886
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11
- **Primary completion:** 2028-03
- **Final completion:** 2028-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-11-17

## Collaborators

- CareDx
- Montreal Heart Institute
- London Health Sciences Centre
- Ottawa Heart Institute Research Corporation
- Traferox Technology Inc.

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07230886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07230886, "Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07230886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*